Vicki V. Baker - Concepedia

Author

Vicki V. Baker

The University of Texas MD Anderson Cancer Center

Also Known As

V BAKER, V Baker, V V Baker, V. Baker, V. V. BAKER, V. V. Baker, V.V Baker, V.V. Baker, VICKI BAKER, VICKI V. BAKER

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of Michigan University of Alabama at Birmingham University of North Carolina at Chapel Hill University of Arkansas for Medical Sciences

About

Vicki V. Baker is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, obstetrics, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.1K
2	Public Health	5	5	282
3	Cell Biology	5	5	155
4	Biomolecular Engineering	1	1	17
5	Blood Transplantation	1	1	10

Vicki V. Baker

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Clinical and Histopathologic Factors Predicting Recurrence and Survival After Pelvic Exenteration for Cancer of the Cervix Hugh M. Shingleton, Seng‐Jaw Soong, Mark S. Gelder, American Journal of Obstetrics and Gynecology	1989	180
Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial Charles E. Butterworth, Kenneth D. Hatch, Seng-Jaw Soong, American Journal of Obstetrics and Gynecology Cervical CancerCervical HealthGynecologyReproductive MedicineClinical Intervention Trial	1992	149
c-myc amplification in ovarian cancer Vicki V. Baker, Matthew P. Borst, Diane Dixon, Gynecologic Oncology MedicineGynecologyC-myc AmplificationOncologyTumor Biology	1990	133
Transcriptional regulation of two genes specifically induced by glucose starvation in a hamster mutant fibroblast cell line. Amy S. Lee, Angelo M. Delegeane, Vicki V. Baker, Journal of Biological Chemistry	1983	127
Postoperative Adjuvant Cisplatin, Doxorubicin, and Cyclophosphamide (PAC) Chemotherapy in Women with High-Risk Endometrial Carcinoma Thomas W. Burke, David M. Gershenson, Mitchell Morris, Gynecologic Oncology Gynecological SurgeryMedicineMetronomic TherapyGynecologyPostoperative Adjuvant Cisplatin	1994	85
Bcl-xLIs Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced Apoptosis J.Rebecca Liu, Bridget Fletcher, Carmen Page, Gynecologic Oncology MedicineApoptosisImmunologyOvarian CarcinomaCancer Biology	1998	85
Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin M. Potter, Kenneth D. Hatch, Michelle Y. Potter, Cancer	1989	72
P 16 Overexpression: A potential early indicator of transformation in ovarian carcinoma Kazushi Shigemasa, Changjun Hu, Carol West, Journal of the Society for Gynecologic Investigation Potential Early IndicatorTumoral PathologyOncologyEndocrine-related CancerP 16	1997	66
Pelvic exenteration with low rectal anastomosis: Survival, complications, and prognostic factors Kenneth D. Hatch, Mark S. Gelder, Seng-Jaw Soong, Gynecologic Oncology Prognostic FactorsSurgical OncologyColorectal SurgeryPelvic ProlapseGastroenterology	1990	66
Cervical intraepithelial neoplasia and cervical cancer. Michael B. Morris, Guillermo Tortolero‐Luna, Anaís Malpica, PubMed	1996	63

Page 1